Evidence map›Paper›PMID 30285892›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.

Changliang Chen, Anitha K Shenoy, Ravi Padia, Dongdong Fang, Qing Jing, Ping Yang, Shi-Bing Su, Shuang Huang

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. An insight into the therapeutic effects of isoliquiritigenin in breast cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  8. [Isoliquiritigenin Modulates the Effect of LINC01503 
on Lung Squamous Carcinoma Cells].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024
    Article
  9. Review
  10. A Novel Tri-Hydroxy-Methylated Chalcone Isolated fromInternational journal of molecular sciences · 2023
    Article
  11. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Changliang ChenResearch Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Anitha K ShenoyDepartment of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
Ravi PadiaDepartment of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
Dongdong FangResearch Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Qing JingDepartment of Cardiology, Changhai Hospital, Shanghai, China.
Ping YangInstrumental Analysis Center, School of Pharmacy, Fudan University, Shanghai, China.
Shi-Bing SuResearch Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, Shanghai, China. shibingsu07@163.com.
Shuang HuangResearch Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, Shanghai, China. shuanghuang@ufl.edu.
Florida College · USShanghai University of Traditional Chinese Medicine · CNFudan University · CNSecond Military Medical University · CN

Funding

Impact of microRNA processing on EMT of ovarian cancer cellsR01CA222467 · NCI · UNIVERSITY OF FLORIDA · PI HUANG, SHUANG · 2018 to 2022
$1.7M
Role of SHOX2 in breast tumor progression and metastasisR01CA187152 · NCI · UNIVERSITY OF FLORIDA · PI HUANG, SHUANG · 2014 to 2018
$1.6M
NCI NIH HHS CA 187152NCI NIH HHS CA222467NCI NIH HHS R01 CA187152NCI NIH HHS R01 CA222467
6 · The paper itself

Abstract

backgroundLicorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this study, we systematically analyzed known licorice's constituents on the goal of identifying component(s) that can effectively suppress both cell migration and growth.

methodsEffect of licorice's constituents on cell growth was evaluated by MTT assay while cell migration was assessed by both wound-healing and Transwell assays. Cytoskeleton reorganization and focal adhesion assembly were visualized by immunofluorescence staining with labeled phalloidin and anti-paxillin antibody. Activity of Src in cells was judged by western blot using phosphor-Src416 antibody while Src kinase activity was measured using Promega Src kinase assay system. Anti-tumorigenic capabilities of isoliquiritigenin (ISL) and 2, 4, 2', 4'-Tetrahydroxychalcone (THC) were investigated using lung cancer xenograft model.

resultsUsing a panel of lung cancer cell lines, ISL was identified as the only licorice's constituent capable of inhibiting both cell migration and growth. ISL-led inhibition in cell migration resulted from impaired cytoskeleton reorganization and focal adhesion assembly. Assessing the phosphorylation of 141 cytoskeleton dynamics-associated proteins revealed that ISL reduced the abundance of Tyr421-phosphorylation of cortactin, Tyr925- and Tyr861-phosphorylation of FAK, indicating the involvement of Src because these sites are known to be phosphorylated by Src. Enigmatically, ISL inhibited Src in cells while displayed no effect on Src activity in cell-free system. The discrepancy was explained by the observation that THC, one of the major ISL metabolite identified in lung cancer cells abrogated Src activity both in cells and cell-free system. Similar to ISL, THC deterred cell migration and abolished cytoskeleton reorganization/focal adhesion assembly. Furthermore, we showed both ISL and THC suppressed in vitro lung cancer cell invasion and in vivo tumor progression.

conclusionOur study suggests that ISL inhibits lung cancer cell migration and tumorigenesis by interfering with Src through its metabolite THC. As licorice is safely used for culinary purposes, our study suggests that ISL or THC may be safely used as a Src inhibitor.

Indexed as

ActinsAnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementChalconesCytoskeletonDisease ProgressionDrug Screening Assays, AntitumorEnzyme InhibitorsFocal AdhesionsGlycyrrhizaHumansLung NeoplasmsMiceMice, NudeActinsChalconesEnzyme InhibitorsisoliquiritigeninPlant Extractssrc-Family KinasesCell migrationIsoliquitigeninLung cancerMetaboliteSrc

Identifiers

PMID30285892
PMCPMC6171243
OpenAlexW2895099230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.